Core 3: Communications, Administrations, Advocacy, and Project Management
核心 3:沟通、行政、宣传和项目管理
基本信息
- 批准号:10628613
- 负责人:
- 金额:$ 26.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-08 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AchievementAdvocacyAdvocateBreast Cancer TreatmentBudgetsClinicalClinical Drug DevelopmentCollaborationsCommunicationElementsEnsureFriendsGenerationsGoalsHuman ResourcesIndividualInfrastructureLeadershipMagnetic Resonance ImagingMeasurableMeasuresMethodologyModificationOffice of Administrative ManagementOutcomeParticipantPatient-Focused OutcomesPatientsProgram Research Project GrantsProtocols documentationRegimenRegulatory PathwayReportingResearch PersonnelRoleScienceSequential TreatmentSpecific qualifier valueStructureSubgroupTrainingTranslatingTranslational ResearchWorkdesignimaging biomarkerimprovedmalignant breast neoplasmmeetingsmolecular markernext generationnoveloperationpersonalized medicineprogramsresponse biomarkerrestrainttimelinetooltreatment responsetreatment strategytrial designwebinarworking group
项目摘要
The Program Project encompasses four integrated projects to develop and maintain the infrastructure for developing and
implementing improvements in the I-SPY2.2 trial that employs early escalation/de-escalation of treatment and identifies
treatment strategies to optimize patient outcomes within a regulatory evidence generation framework. The primary aims
of the Communications, Administration, Advocacy, and Project management (CAAP) Core are to ensure program
integration, collaboration, patient acceptance, and regulatory compliance by providing project management, leadership,
and administrative support to all Projects and Cores; as well as the integration of advocacy in all patient-facing aspects of
the Projects and Core in the Program Project.
Perhaps the most critical role of the CAAP core is to coordinate the activities and deliverables of the projects and cores
with the study sponsor QLHC, its clinical operations team and the I-SPY2 trial working group chairs. While program
project personnel, cores and projects are tasked with developing and refining the technical and methodological advances
required in the continuous improvement approach employed in I-SPY2.2, all operational aspects of the trial are the
responsibility of the study sponsor. The Program Project overall PIs and project PIs, facilitated by the CAAP core, work
to integrate the changes into the operations of the trial with sponsor representatives by defining the technical
requirements, specifications, and deliverables for the sponsor’s clinical operations team.
Among its other responsibilities, the CAAP Core ensures that our patient advocates are represented on all project teams,
cores teams and inter-project collaborations, so that they can bring their unique and important perspective to help meet the
patient-centric mandate of I-SPY2.2.
Specific Aim 1: Organize, integrate, and provide administrative management of all Projects and Core
Specific Aim 2: Provide project management oversight to track milestones and timelines of the individual Projects and
Cores.
Specific Aim 3: Facilitate collaborations and disseminate information
该计划项目包括四个综合项目,旨在开发和维护开发和维护基础设施
在 I-SPY2.2 试验中实施改进,采用早期升级/降级治疗并确定
主要目标是在监管证据生成框架内优化患者治疗结果。
沟通、行政、宣传和项目管理 (CAAP) 核心的职责是确保计划
通过提供项目管理、领导力、整合、协作、患者接受度和法规遵从性,
对所有项目和核心的行政支持,以及将宣传整合到所有面向患者的方面;
计划项目中的项目和核心。
也许 CAAP 核心最关键的作用是协调项目和核心的活动和可交付成果
与研究申办者 QLHC、其临床操作团队和 I-SPY2 试验工作组主席 While 项目一起。
项目人员、核心和项目的任务是开发和完善技术和方法的进步
根据 I-SPY2.2 中采用的持续改进方法的要求,试验的所有操作方面都是
该计划的总体 PI 和项目 PI 在 CAAP 核心的推动下发挥作用。
通过定义技术,将变更整合到申办者代表的试验操作中
申办者临床运营团队的要求、规范和可交付成果。
除其他职责外,CAAP 核心还确保我们的患者倡导者在所有项目团队中都有代表,
核心团队和项目间协作,以便他们能够带来独特而重要的视角来帮助满足
I-SPY2.2 以患者为中心的任务。
具体目标 1:组织、整合并提供所有项目和核心的行政管理
具体目标 2:提供项目管理监督,以跟踪各个项目和项目的里程碑和时间表
核心。
具体目标 3:促进合作和传播信息
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAURA J ESSERMAN其他文献
LAURA J ESSERMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAURA J ESSERMAN', 18)}}的其他基金
Extending the Diversity, Reach, and Generalizability of the WISDOM Study
扩展 WISDOM 研究的多样性、范围和普遍性
- 批准号:
10368970 - 财政年份:2020
- 资助金额:
$ 26.66万 - 项目类别:
Extending the Diversity, Reach, and Generalizability of the WISDOM Study
扩展 WISDOM 研究的多样性、范围和普遍性
- 批准号:
9888251 - 财政年份:2020
- 资助金额:
$ 26.66万 - 项目类别:
Extending the Diversity, Reach, and Generalizability of the WISDOM Study
扩展 WISDOM 研究的多样性、范围和普遍性
- 批准号:
10593908 - 财政年份:2020
- 资助金额:
$ 26.66万 - 项目类别:
Enhancing the Diversity of Participants in the WISDOM Clinical Trial: Practical Challenges and Ethical Implications
增强 WISDOM 临床试验参与者的多样性:实际挑战和伦理影响
- 批准号:
10367828 - 财政年份:2020
- 资助金额:
$ 26.66万 - 项目类别:
Extending the Diversity, Reach, and Generalizability of the WISDOM Study
扩展 WISDOM 研究的多样性、范围和普遍性
- 批准号:
10593908 - 财政年份:2020
- 资助金额:
$ 26.66万 - 项目类别:
I-SPY2 +: Evolving the I-SPY 2 TRIAL to include MRI-directed, adaptive sequential treatment to optimize breast cancer outcomes
I-SPY2:改进 I-SPY 2 试验,纳入 MRI 引导的适应性序贯治疗,以优化乳腺癌结果
- 批准号:
9360068 - 财政年份:2017
- 资助金额:
$ 26.66万 - 项目类别:
相似国自然基金
面向社交电商的产品虚假宣传防治关键技术研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
关键金属重大研究计划科普宣传与公共服务
- 批准号:92162320
- 批准年份:2021
- 资助金额:100 万元
- 项目类别:地区科学基金项目
基于社交媒体用户行为的个性化电影宣传片生成方法研究
- 批准号:
- 批准年份:2019
- 资助金额:24 万元
- 项目类别:青年科学基金项目
基于社交媒体用户行为的个性化电影宣传片生成方法研究
- 批准号:61902201
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
敬畏感对于不诚信行为的多维影响和应用研究:基于营销诚信及诚信宣传的视角
- 批准号:71672169
- 批准年份:2016
- 资助金额:48.0 万元
- 项目类别:面上项目
相似海外基金
myAURA: Personalized Web Service for Epilepsy Management
myAURA:用于癫痫管理的个性化 Web 服务
- 批准号:
10414826 - 财政年份:2021
- 资助金额:
$ 26.66万 - 项目类别:
Geriatric Oncology Research Infrastructure to Improve Clinical Care
改善临床护理的老年肿瘤学研究基础设施
- 批准号:
10667860 - 财政年份:2018
- 资助金额:
$ 26.66万 - 项目类别: